GenVec, Inc.
GNVC
GNVC was delisted on the 15th of June, 2017.
24 hedge funds and large institutions have $10.4M invested in GenVec, Inc. in 2014 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
541% more capital invested
Capital invested by funds: $1.63M → $10.4M (+$8.79M)
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
33% more funds holding
Funds holding: 18 → 24 (+6)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$4.33M |
| 2 |
PA
Perceptive Advisors
New York
|
+$2.67M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.87M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$543K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$326K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$42.1K |
| 2 |
RCP
Rho Capital Partners
New York
|
-$42K |
| 3 |
Citigroup
New York
|
-$3.62K |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
-$2K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$1.04K |
GNVC Hedge Fund Activity: Q1 2014 in Review
24 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in GenVec, Inc. (GNVC) for Q1 2014, worth a combined $10.4M — up 541% from $1.63M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new GNVC positions and 3 closed out — a net gain of 6 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $4.33M. The largest seller was Tower Research Capital (TRC), cutting an estimated $42.1K.
- 24 institutional investors held GenVec, Inc. (GNVC) as of Q1 2014, up from 18 in Q4 2013.
- Funds reported $10.4M of GenVec, Inc. stock for Q1 2014, up 541% quarter-over-quarter.
- 9 funds opened new GenVec, Inc. positions in Q1 2014 and 3 closed out, a net change of +6 holders.
- The largest GenVec, Inc. buyer in Q1 2014 was Cormorant Asset Management, an estimated $4.33M added.
- The largest GenVec, Inc. seller in Q1 2014 was Tower Research Capital (TRC), an estimated $42.1K sold.
Based on aggregated 13F filings for Q1 2014.